Myelodysplastic Syndrome (MDS)
Myelodysplastic Syndrome (MDS) is a group of disorders caused by poorly formed or dysfunctional blood cells, leading to symptoms like fatigue, weakness, and increased risk of infections.
Acute Myeloid Leukemia: MP0533 Treatment Study
We are testing a new drug, MP0533, for patients with acute myeloid leukemia or myelodysplastic syndrome. The study aims to evaluate its safety and how well it may work against these blood cancers.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Acute Myeloid Leukemia (AML)
Acute Myeloid Leukemia (AML) is a type of cancer that affects the blood and bone marrow, characterized by the rapid growth of abnormal white blood cells, leading to symptoms such as fatigue, fever, and easy bruising.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you at least 18 years old?
- Do you have relapsed or refractory acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS)?
- Have you had major surgery in the past 28 days?
- Are you currently taking any immunosuppressive drugs, like prednisone (or equivalent) more than 10mg daily?
- Do you have any uncontrolled active infections?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Mp0533
What similar medicines might you know?
Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.
Azacitdine Clonmel
Azacitidin
Azacitidin Aliud
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Centre Hospitalier Universitaire De Bordeaux
Service d'Hématologie et thérapie cellulaire
Canéjan, France
Institut Claudius Regaud
Département d' Hématologie
Portet-sur-Garonne, France
Assistance Publique Hopitaux De Paris
Service Hématologie Greffe Adolescents et Jeunes Adultes
Quinze-Vingts, France
Sponsor: Molecular Partners AG
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.